ArticlePloS one2010

TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.

Josep Maria Lluis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.